2.4.0.8114 - Disclosure - Other Assetstruefalsefalse1falsefalsefalseeol_PE10315---1310-Q0011_STD_181_20130630_0http://www.sec.gov/CIK0001069308duration2013-01-01T00:00:002013-06-30T00:00:001false4opxa_OtherAssetsNoncurrentDisclosureTextBlockopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">
Note 6.  Other Assets</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div>
<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other
long-term assets at June 30, 2013 consist of legal costs incurred
from third parties in conjunction with the Merck
Agreement.  These costs were capitalized and are
amortized to general and administrative expenses on the
consolidated statements of operations in conjunction with the
recognition of revenue on a straight-line basis over the exclusive
option period based on the term of the Phase IIb clinical trial in
SPMS. During the six months ended June 30, 2013, Opexa amortized
$17,782 of legal costs to general and administrative expenses on
the consolidated statements of operations.  Opexa
included the current portion of the legal costs of $44,070 in other
current assets on the consolidated balance sheets and the long term
portion of the legal costs of $96,064 in other long-term assets on
the consolidated balance sheets as of June 30, 2013.</font></div>
</div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of the major components of noncurrent assets not separately presented in the balance sheet due to materiality considerations.No definition available.false0falseOther AssetsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsNoncurrentDisclosureTextBlock11